Therapeutic Advances in Infectious Disease

Title Publication Date Language Citations
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs2021/01/01English16
Optimal treatment of HIV-associated neurocognitive disorders: myths and reality. A critical review2019/01/01English15
Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure2019/01/01English15
Risk of infection associated with targeted therapies for solid organ and hematological malignancies2021/01/01English14
Management of febrile neutropenia in the era of bacterial resistance2013/02/01English13
Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia2017/09/12English13
Antiretroviral adherence for adolescents growing up with HIV: understanding real life, drug delivery and forgiveness2020/01/01English13
Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster2020/01/01English12
Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs2019/01/01English12
A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection2017/05/01English11
Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity2014/04/01English11
SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID2021/01/01English11
The impact of COVID-19 on tuberculosis: challenges and opportunities2021/01/01English11
The implications of whole-genome sequencing in the control of tuberculosis2015/12/30English11
Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports2013/07/22English11
An exercise intervention alters stool microbiota and metabolites among older, sedentary adults2021/01/01English11
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City2022/01/01English11
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens2017/03/01English11
Urogenital tuberculosis: definition and classification2014/10/01English11
Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management2021/01/01English10
The management of treatment-experienced HIV patients (including virologic failure and switches)2020/01/01English10
Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid2017/01/01English10
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia2019/01/01English10
Antimicrobial effects of lysophosphatidylcholine on methicillin-resistant Staphylococcus aureus2017/07/01English10
Current tools available for the diagnosis of drug-resistant tuberculosis2016/10/15English10
Bloodstream infections and antimicrobial sensitivity patterns in a tertiary care hospital of India2016/10/01English9
Treatment optimization for HIV/HCV co-infected patients2016/12/09English9
Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient2018/07/10English9
Management of BK virus-associated haemorrhagic cystitis in allogeneic stem cell transplant recipients2021/01/01English9
The current status of community-acquired pneumonia management and prevention in children under 5 years of age in India: a review2016/06/01English9